BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38549459)

  • 1. Standardized uptake value
    Jin B; Wen X; Tian H; Guo H; Hao M; Wu J; Li X; Ren Y; Wang X; Ren X
    Cancer Med; 2024 Apr; 13(7):e6961. PubMed ID: 38549459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactate dehydrogenase and serum tumor markers for predicting metastatic status in geriatric patients with lung adenocarcinoma.
    Ren X; Zhang Y; Lyu Y; Jin B; Guo H; Wu J; Li X; Liu X
    Cancer Biomark; 2019; 26(2):139-150. PubMed ID: 31356196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Utility of Multiple Increased Lung Cancer Tumor Markers in Treatment of Patients with Advanced Lung Adenocarcinoma].
    Peng Y; Wang Y; Hao X; Li J; Liu Y; Wang H
    Zhongguo Fei Ai Za Zhi; 2017 Oct; 20(10):690-694. PubMed ID: 29061216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
    Ma L; Xie XW; Wang HY; Ma LY; Wen ZG
    Asian Pac J Cancer Prev; 2015; 16(12):4891-4. PubMed ID: 26163610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Seven Clinical Tumor Markers in Diagnosis of Non-Small-Cell Lung Cancer.
    Chen ZQ; Huang LS; Zhu B
    Dis Markers; 2018; 2018():9845123. PubMed ID: 30647803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Combination of CA125 and NSE Is Useful for Predicting Liver Metastasis of Lung Cancer.
    Wang CF; Peng SJ; Liu RQ; Yu YJ; Ge QM; Liang RB; Li QY; Li B; Shao Y
    Dis Markers; 2020; 2020():8850873. PubMed ID: 33376560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective Study to Determine Diagnostic Utility of 6 Commonly Used Lung Cancer Biomarkers Among Han and Uygur Population in Xinjiang Uygur Autonomous Region of People's Republic of China.
    Yang-Chun F; Min F; Di Z; Yan-Chun H
    Medicine (Baltimore); 2016 May; 95(18):e3568. PubMed ID: 27149479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
    Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Pleural Invasion in Challenging Non-Small-Cell Lung Cancer Patients Using Serum and Imaging Markers.
    Zhu K; Chen L; He C; Lang Y; Kong X; Qu C; Xu S
    Dis Markers; 2020; 2020():6430459. PubMed ID: 32089756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients.
    Zhang L; Liu D; Li L; Pu D; Zhou P; Jing Y; Yu H; Wang Y; Zhu Y; He Y; Li Y; Zhao S; Qiu Z; Li W
    BMC Cancer; 2017 Feb; 17(1):96. PubMed ID: 28152979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Serum Tumor Markers for Predicting Ocular Metastasis in Lung Adenocarcinoma: A Retrospective Study.
    Shi WQ; Liu WF; Li B; Lin Q; Li QH; Zhang YQ; Yuan Q; Liang RB; Ge QM; Shao Y
    Dis Markers; 2020; 2020():2102158. PubMed ID: 32685054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between Serum Tumor Markers and Efficacy of First-line EGFR-TKIs in Patients with Advanced Lung Adenocarcinoma].
    Chen H; Yang X; Liu H; Ma K; Zhong J; Dong Z; Zhuo M; Wang Y; Li J; An T; Wu M; Wang Z; Zhao J
    Zhongguo Fei Ai Za Zhi; 2017 Sep; 20(9):589-597. PubMed ID: 28935011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum tumor markers level and their predictive values for solid and micropapillary components in lung adenocarcinoma.
    Li Z; Wu W; Pan X; Li F; Zhu Q; He Z; Chen L
    Cancer Med; 2022 Jul; 11(14):2855-2864. PubMed ID: 35289087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
    Jiang ZF; Wang M; Xu JL
    Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical Significance of Tumor Marker Detection in Patients 
with Advanced Squamous Cell Carcimoma of the Lung].
    Liang P; Li J
    Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):641-647. PubMed ID: 27760591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive reactions for both Cyfra21-1 and CA125 indicate worst prognosis in non-small cell lung cancer.
    Ando S; Kimura H; Iwai N; Yamamoto N; Iida T
    Anticancer Res; 2003; 23(3C):2869-74. PubMed ID: 12926125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
    Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
    Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of LDH, CA125 and CYFRA21-1 in tuberculosis pleural effusion.
    Lin H; Ni L
    Med Clin (Barc); 2022 Jan; 158(2):70-72. PubMed ID: 33495032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined detection of serum IL-6 and CEA contributes to the diagnosis of lung adenocarcinoma
    Pan J; Zhuang W; Xia Y; Huang Z; Zheng Y; Wang X; Huang Y
    PeerJ; 2024; 12():e17141. PubMed ID: 38529301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical value of CEA and CYFRA21-1 as an assessment indicator of therapeutic efficacy in advanced non-small cell lung cancer patients].
    Li L; Song LH; Ding SC; Zhang XJ; Qiang L; Han CY; Yuan XT; Xu DD
    Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):850-4. PubMed ID: 21223692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.